These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells. Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519 [TBL] [Abstract][Full Text] [Related]
4. Involvement of PU.1 in the transcriptional regulation of TNF-alpha. Fukai T; Nishiyama C; Kanada S; Nakano N; Hara M; Tokura T; Ikeda S; Ogawa H; Okumura K Biochem Biophys Res Commun; 2009 Oct; 388(1):102-6. PubMed ID: 19646961 [TBL] [Abstract][Full Text] [Related]
5. PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells. Yashiro T; Kubo M; Ogawa H; Okumura K; Nishiyama C PLoS One; 2015; 10(9):e0137699. PubMed ID: 26361334 [TBL] [Abstract][Full Text] [Related]
6. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. Sharma SM; Bronisz A; Hu R; Patel K; Mansky KC; Sif S; Ostrowski MC J Biol Chem; 2007 May; 282(21):15921-9. PubMed ID: 17403683 [TBL] [Abstract][Full Text] [Related]
7. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. Yagi M; Ninomiya K; Fujita N; Suzuki T; Iwasaki R; Morita K; Hosogane N; Matsuo K; Toyama Y; Suda T; Miyamoto T J Bone Miner Res; 2007 Jul; 22(7):992-1001. PubMed ID: 17402846 [TBL] [Abstract][Full Text] [Related]
8. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis. Izawa N; Kurotaki D; Nomura S; Fujita T; Omata Y; Yasui T; Hirose J; Matsumoto T; Saito T; Kadono Y; Okada H; Miyamoto T; Tamura T; Aburatani H; Tanaka S J Bone Miner Res; 2019 Jun; 34(6):1143-1154. PubMed ID: 30721543 [TBL] [Abstract][Full Text] [Related]
9. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. Kim K; Kim JH; Lee J; Jin HM; Lee SH; Fisher DE; Kook H; Kim KK; Choi Y; Kim N J Biol Chem; 2005 Oct; 280(42):35209-16. PubMed ID: 16109714 [TBL] [Abstract][Full Text] [Related]
10. Mitf-PU.1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation. Partington GA; Fuller K; Chambers TJ; Pondel M Bone; 2004 Feb; 34(2):237-45. PubMed ID: 14962802 [TBL] [Abstract][Full Text] [Related]
11. The hematopoietic cell-specific transcription factor PU.1 is critical for expression of CD11c. Yashiro T; Kasakura K; Oda Y; Kitamura N; Inoue A; Nakamura S; Yokoyama H; Fukuyama K; Hara M; Ogawa H; Okumura K; Nishiyama M; Nishiyama C Int Immunol; 2017 Feb; 29(2):87-94. PubMed ID: 28338898 [TBL] [Abstract][Full Text] [Related]
12. C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1. Chen W; Zhu G; Tang J; Zhou HD; Li YP J Pathol; 2018 Mar; 244(3):271-282. PubMed ID: 29083488 [TBL] [Abstract][Full Text] [Related]
13. Critical Roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2. Inage E; Kasakura K; Yashiro T; Suzuki R; Baba Y; Nakano N; Hara M; Tanabe A; Oboki K; Matsumoto K; Saito H; Niyonsaba F; Ohtsuka Y; Ogawa H; Okumura K; Shimizu T; Nishiyama C J Immunol; 2014 Apr; 192(8):3936-46. PubMed ID: 24639354 [TBL] [Abstract][Full Text] [Related]
14. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors. Hu R; Sharma SM; Bronisz A; Srinivasan R; Sankar U; Ostrowski MC Mol Cell Biol; 2007 Jun; 27(11):4018-27. PubMed ID: 17403896 [TBL] [Abstract][Full Text] [Related]
15. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189 [TBL] [Abstract][Full Text] [Related]
16. MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR. Kim JH; Kim K; Youn BU; Jin HM; Kim N Cell Signal; 2010 Sep; 22(9):1341-9. PubMed ID: 20466061 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB. Kim WS; Kim HJ; Lee ZH; Lee Y; Kim HH Exp Cell Res; 2013 Feb; 319(4):436-46. PubMed ID: 23246654 [TBL] [Abstract][Full Text] [Related]
18. Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. Luchin A; Suchting S; Merson T; Rosol TJ; Hume DA; Cassady AI; Ostrowski MC J Biol Chem; 2001 Sep; 276(39):36703-10. PubMed ID: 11481336 [TBL] [Abstract][Full Text] [Related]
19. Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells. Miura R; Kasakura K; Nakano N; Hara M; Maeda K; Okumura K; Ogawa H; Yashiro T; Nishiyama C PLoS One; 2016; 11(4):e0154094. PubMed ID: 27105023 [TBL] [Abstract][Full Text] [Related]
20. Stimuli and Relevant Signaling Cascades for NFATc1 in Bone Cell Homeostasis: Friend or Foe? Zhang Z; Wen H; Yang X; Zhang K; He B; Zhang X; Kong L Curr Stem Cell Res Ther; 2019; 14(3):239-243. PubMed ID: 30516111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]